Cargando…
Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years
Estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2) are the mainstay of breast cancer management, and their prevalence rates vary among different populations possibly related to ethnic/genetic and/or socioeconomic status. In a previous study co...
Autores principales: | Alsughayer, Anas M., Dabbagh, Tamara Z., Abdel-Razeq, Rashid H., Al-Jussani, Ghada N., Alhassoon, Salam, Sughayer, Maher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302262/ https://www.ncbi.nlm.nih.gov/pubmed/35436143 http://dx.doi.org/10.1200/GO.21.00359 |
Ejemplares similares
-
Association of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression with Breast Cancer Metastasis in Iran
por: Jafari, Seyed Hamed, et al.
Publicado: (2022) -
Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan
por: Almasri, Nidal M, et al.
Publicado: (2005) -
Trends in estrogen and progesterone receptors in prostate cancer: a bibliometric analysis
por: Liao, Wenqiang, et al.
Publicado: (2023) -
Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice
por: KISHI, SOSUKE, et al.
Publicado: (2014) -
Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2012)